GoodRx Holdings, Inc.GDRXNASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P33
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | -2.20% |
| 2024 | -8.90% |
| 2023 | -5.10% |
| 2022 | 13.73% |
| 2021 | 103.60% |
| 2020 | 110.98% |
| 2019 | -33.25% |
| 2018 | 281.65% |
| 2017 | 100.30% |
| 2016 | 0.00% |